Paediatric chronic asthma management
respiratory · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Long-term control of childhood asthma using a stepwise approach based on symptom control, exacerbation frequency and inhaler technique. Current guidance favours inhaled corticosteroid-containing therapy as the controller backbone rather than reliever monotherapy.
Red flags
- Frequent exacerbations or any life-threatening attack
- Rising reliever use (more than monthly salbutamol inhalers)
- Poor growth on high-dose steroids
- Persistent symptoms despite good adherence and technique (consider alternative diagnosis)
Assessment
Differential diagnosis
- Preschool viral/multi-trigger wheeze
- Inhaled foreign body
- Bronchiolitis or recurrent viral LRTI
- Cystic fibrosis or primary ciliary dyskinesia
- Dysfunctional breathing / vocal cord dysfunction
- Cardiac or structural airway disease
- Chronic cough from other cause (e.g. protracted bacterial bronchitis)
Investigations
- Diagnosis supported by history of variable wheeze/cough/breathlessness and response to treatment
- Spirometry with bronchodilator reversibility in children able to perform (usually over 5)
- FeNO where available to support eosinophilic inflammation
- Peak flow diary in older children
- Assess inhaler technique and adherence at each review
- Allergy testing/chest X-ray only if diagnostic doubt or red flags
Management
- Confirm diagnosis objectively where possible and identify triggers
- Assess control (symptoms, reliever use, night waking, exacerbations, absence)
- Check and correct inhaler technique and spacer use at every visit
- Start/maintain regular inhaled corticosteroid-containing controller therapy
- Step up (add LABA/LTRA or increase ICS) if control inadequate despite good technique/adherence
- Consider ICS-formoterol maintenance-and-reliever regimens in suitable older children
- Provide a written personalised asthma action plan
- Address triggers, smoking exposure, allergen avoidance and vaccination
- Step down therapy once stable; refer to specialist if uncontrolled on moderate-dose therapy
Drugs & doses
Inhaled corticosteroid via spacer, e.g. beclometasone 100-200 microgram twice daily (low paediatric dose), titrated to control
Montelukast 4 mg (2-5 yr) or 5 mg (6-14 yr) PO nocte as add-on controller
Salbutamol 100-200 microgram inhaled via spacer as reliever as required
ICS/formoterol combination inhaler for maintenance-and-reliever therapy in older children per step
Disposition
Primary care/paediatric outpatient with regular structured review; refer to specialist if uncontrolled on moderate therapy or diagnostic doubt.
Complications & pitfalls
- Acute severe exacerbations and hospital admission
- Growth suppression and adrenal effects from high-dose steroids
- Fixed airflow limitation if poorly controlled
- Reduced quality of life, school absence and exercise limitation
Exam pearls
- Never treat asthma with short-acting reliever alone; an ICS-containing controller is the backbone
- Over-reliance on salbutamol is a marker of poor control and risk
- Most poor control is due to technique or adherence, not drug failure
- Review and step down once stable to use the lowest effective dose
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.